UPDATE : Monday, December 16, 2019
상단여백
Bayer drugs out of stock in Korea
Bayer is having trouble supplying its drug in the local market as the compa...
by Lee Han-soo  |  2019-10-11 16:36
라인
Sanofi to cover part of Dupixent cost for atopic dermatitis patients
Sanofi said it would run a program to support part of the cost of Dupixent,...
by Kim Yun-mi  |  2019-10-11 15:13
라인
Takeda Korea’s labor union goes on strike
The conflict between Takeda Korea's management and labor union has reac...
by Lee Han-soo  |  2019-10-11 14:33
라인
Roche’s Tecentriq combo therapy shows encouraging results
Roche Korea said the company had presented results from a phase 1b study ev...
by Lee Han-soo  |  2019-10-10 17:36
라인
Yuyu confirms safety of its antiplatelet drug
Yuyu Pharmaceutical said that it has confirmed the safety of Yuclid (ingred...
by Lee Han-soo  |  2019-10-10 17:35
라인
Doctors call Boehringer Ingelheim’s Jardiance marketing ‘unethical’
The medical community criticized Boehringer Ingelheim Korea’s recent releas...
by Kim Yun-mi  |  2019-10-10 16:01
라인
FDA OKs AbbVie’s Hepatitis C drug to shorten treatment duration
AbbVie said that the U.S. Food and Drug Administration (FDA) has approved M...
by Lee Han-soo  |  2019-10-08 18:04
라인
Allergan Korea to replace breast implant without time limit
Allergan Korea CEO Kim Ji-hyun said she would lift the two-year time limit ...
by Lee Hye-seon  |  2019-10-08 15:22
라인
Most of weight loss drug Saxenda irregularly distributed
Saxenda, a prescription medicine for weight loss, gained immense popularity...
by Kwak Sung-sun  |  2019-10-08 15:19
라인
Yuyang DNU, NSCI to develop treatment for dry macular degeneration
Yuyang DNU and Neural Stem Cell Institute (NSCI), a U.S. NGO research insti...
by Lee Han-soo  |  2019-10-07 16:54
라인
Sanofi confirms prolonged PFS in patients with advanced gastric cancer
Sanofi has published the results of a clinical trial PRODIGY, which evaluat...
by Lee Han-soo  |  2019-10-07 14:39
라인
Galderma Korea workers feel insecure after separation from Nestle
Galderma has debuted as a rebranded dermatology company after separation fr...
by Kim Yun-mi  |  2019-10-07 14:38
라인
Albis most prescribed ranitidine drug with carcinogen risk
Physicians have prescribed Albis Tab. the most among ranitidine-containing ...
by Kwak Sung-sun  |  2019-10-07 11:23
라인
Qurient sets up joint firm with Nobel chemistry prize winner
Qurient has established a joint venture with Professors Robert Huber, a res...
by Lee Han-soo  |  2019-10-04 17:45
라인
Lilly's Verzenio extends life for women with advanced breast cancer
Lilly said a combination therapy of Verzenio and fulvestrant significantly ...
by Lee Han-soo  |  2019-10-04 16:15
라인
Eisai’s hepatocellular carcinoma treatment Lenvima to get insurance benefit
The government said it would grant insurance benefit to Eisai’s Lenvima (in...
by Lee Han-soo  |  2019-10-02 16:10
라인
CDK4/6 inhibitor+fulvestrant combo nears getting benefit
The combination therapy of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor ...
by Kim Yun-mi  |  2019-10-02 16:03
라인
Daewoong's EU partner wins sales approval for BTX
Daewoong Pharmaceutical said that Evolus, its U.S. and EU partner, has rece...
by Lee Han-soo  |  2019-10-02 14:51
라인
Daewoong's reaffirms drug-marketing power with Daiichi Sankyo's NOAC treatment
Daewoong proved its sales power once again as it solidified its top positio...
by Lee Han-soo  |  2019-10-01 16:43
라인
Drugmakers’ illegal rebates down, support for doctors up
Pharmaceutical companies’ offering of illicit rebates to physicians have de...
by Kwak Sung-sun  |  2019-10-01 13:49
여백
여백
여백
Back to Top